Concepedia

M. Taplin

MT

Statistics

Publications

3

Citations

51

H-Index

3

Active since

2005

Affiliations

PharmaMar (Spain)(Current)

M. Taplin is an author at PharmaMar (Spain) specializing in medicine, oncology, and cancer pharmacology.

Publications per year

2005–2008

3

Publications

3

Impact of prior ketoconazole therapy on response proportion to abiraterone acetate, a 17-alpha hydroxylase C17,20-lyase inhibitor in castration resistant prostate cancer (CRPC)

Charles J. Ryan, Matthew Smith, J. E. Rosenberg et al. · Journal of Clinical Oncology · 2008 · 19 citations

Medicine, Oncology, Pharmacology +17

Phase I trial of RAD001 (R) and docetaxel (D) in castration resistant prostate cancer (CRPC) with FDG-PET assessment of RAD001 activity

Robert W. Ross, Judith Manola, William Oh et al. · Journal of Clinical Oncology · 2008 · 18 citations

Medicine, Oncology, Pharmacology +17

Phase II study of three hour, weekly infusion of trabectedin (ET-743) in men with metastatic, androgen-independent prostate carcinoma (AIPC)

M. Dror Michaelson, Timothy D. Gilligan, William Oh et al. · Journal of Clinical Oncology · 2005 · 14 citations

Medicine, Oncology, Pharmacology +17

1–3 of 3